Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Resolution of pansclerotic morphea after treatment with antithymocyte globulin

Nature Reviews Rheumatology volume 5, pages 513–516 (2009)Cite this article

Abstract

Background. A previously healthy 50-year-old man presented with thickening and hardening of the skin on his trunk, neck and upper extremities that had started after the appearance of a 5 cm web-like patch of blood vessels on his upper chest and progressed over 4 months. He also reported difficulties with swallowing and a 20 kg weight loss.

Investigations. Physical examination, laboratory testing, including complete blood count, autoimmune serology for antiplatelet, antinuclear and extractable nuclear antibodies, direct antiglobulin test, incisional skin biopsy, bone-marrow biopsy, and MRI of the upper extremities.

Diagnosis. Pansclerotic morphea associated with red cell aplasia and immune-mediated thrombocytopenia.

Management. Treatment with prednisone 60 mg per day and methotrexate 15 mg per week was started, but symptoms worsened. Methotrexate was replaced by pulsed intravenous methylprednisolone (1 g daily for 3 days), followed by mycophenolate mofetil started at 1 g per day and titrated up over 4 weeks to 3 g per day. Severe bicytopenia developed that did not improve with an 8-week washout of immunosuppressive agents. His fibrotic skin and hematologic conditions dramatically responded to antithymocyte globulin 40 mg/kg daily for 4 days, plus 10 mg/kg ciclosporin and methylprednisolone 1 mg/kg per day.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Photographs of the patient's skin before treatment and 10 months after administration of ATG and ciclosporin.
Figure 2: Histology of a bone marrow biopsy sample after initial immunosupporessive therapy, showing megakaryocytic and erythroid precursor aplasia.
Figure 3: Timeline of clinical disease course and therapy.

References

  1. Diaz-Perez, J. L., Connolly, S. M. & Winkelmann, R. K. Disabling pansclerotic morphea of children. Arch. Dermatol. 116, 169–173 (1980).

    Article  CAS  PubMed  Google Scholar 

  2. Maragh, S. H., Davis, M. D., Bruce, A. J. & Nelson, A. M. Disabling pansclerotic morphea: clinical presentation in two adults. J. Am. Acad. Dermatol. 53 (2 Suppl. 1), S115–S119 (2005).

    Article  PubMed  Google Scholar 

  3. Herzinger, T., Prinz, J. C. & Röcken, M. Pansclerotic morphea of the head. Arch. Dermatol. 144, 125–126 (2008).

    Article  PubMed  Google Scholar 

  4. Haustein, U. F. Scleroderma and pseudo-scleroderma: uncommon presentations. Clin. Dermatol. 23, 480–490 (2005).

    Article  PubMed  Google Scholar 

  5. Boin, F. & Hummers, L. K. Scleroderma-like fibrosing disorders. Rheum. Dis. Clin. North Am. 34, 199–220 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Westerman, M. P., Martinez, R. C., Medsger, T. A. Jr, Totten, R. S. & Rodnan, G. P. Anemia and scleroderma: frequency, causes, and marrow findings. Arch. Intern. Med. 122, 39–42 (1968).

    Article  CAS  PubMed  Google Scholar 

  7. Doyle, J. A., Connolly, S. M. & Winkelmann, R. K. Cutaneous and subcutaneous inflammatory sclerosis syndromes. Arch. Dermatol. 118, 886–890 (1982).

    Article  CAS  PubMed  Google Scholar 

  8. Kamada, K. et al. Scleroderma associated with anemia and thrombocytopenia that responded well to cyclosporin. Acta Haematol. 104, 106–109 (2000).

    Article  CAS  PubMed  Google Scholar 

  9. Tooze, J. A. et al. Response of aplastic anaemia and scleroderma to cyclosporin. Br. J. Haematol. 85, 829–831 (1993).

    Article  CAS  PubMed  Google Scholar 

  10. Ivey, K. J., Hwang, Y. F. & Sheets, R. F. Scleroderma associated with thrombocytopenia and Coombs-positive hemolytic anemia. Am. J. Med. 51, 815–817 (1971).

    Article  CAS  PubMed  Google Scholar 

  11. Peterson, L. S., Nelson, A. M. & Su, W. P. Classification of morphea (localized scleroderma). Mayo Clin. Proc. 70, 1068–1076 (1995).

    Article  CAS  PubMed  Google Scholar 

  12. Bielsa, I. & Ariza, A. Deep morphea. Semin. Cutan. Med. Surg. 26, 90–95 (2007).

    Article  CAS  PubMed  Google Scholar 

  13. Rosenfeld, S., Follmann, D., Nunez, O. & Young, N. S. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289, 1130–1135 (2003).

    Article  CAS  PubMed  Google Scholar 

  14. Xie, Y. et al. Immunohistochemical characterization of the cellular infiltrate in localized scleroderma. Int. J. Dermatol. 47, 438–442 (2008).

    Article  PubMed  Google Scholar 

  15. Denton, C. P., Korn, J. H., Black, C. M. & de Crombrugghe, B. Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy. Lancet 347, 1453–1458 (1996).

    Article  Google Scholar 

  16. Stratton, R. J., Wilson, H. & Black, C. M. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology (Oxford) 40, 84–88 (2001).

    Article  CAS  Google Scholar 

  17. Suematsu, E., Miyamura, T., Idutsu, K., Minami, R. & Yamamoto, M. Efficacy of anti-thymocyte globulin and cyclosporin A combined therapy in aplastic anemia complicated with limited cutaneous systemic sclerosis [Japanese]. Nihon Rinsho Meneki Gakkai Kaishi 28, 99–103 (2005).

    Article  PubMed  Google Scholar 

  18. Mothy, M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21, 1387–1394 (2007).

    Article  Google Scholar 

Download references

Acknowledgements

Written consent for publication was obtained from the patient.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Johns Hopkins University School of Medicine Baltimore, MD, USA

    Philip Song, Fredrick M. Wigley & Francesco Boin

  2. Department of Pathology, Johns Hopkins University School of Medicine Baltimore, MD, USA

    Christopher Gocke

Authors
  1. Philip Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Gocke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fredrick M. Wigley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco Boin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Boin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, P., Gocke, C., Wigley, F. et al. Resolution of pansclerotic morphea after treatment with antithymocyte globulin. Nat Rev Rheumatol 5, 513–516 (2009). https://doi.org/10.1038/nrrheum.2009.159

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2009.159

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing